Search results
Results From The WOW.Com Content Network
Cannabis in New York has been legal for medical purposes under New York law since 2016, and recreational purposes since 2021. As of 2022, recreational cannabis is for sale legally in the state (including Native American reservations), only through state-approved dispensaries. Adults aged 21 and older are allowed to possess up to 3 ounces (85 g ...
Curaleaf. Curaleaf Holdings, Inc. is an American cannabis company publicly traded on the Canadian stock exchange. The company is headquartered in New York City. Founded in 2010, it produces and distributes cannabis products in North America, operating dispensaries in 19 states. The company is headquartered in New York City, and is the world's ...
July 11, 2014. Sibley and Holmwood Candy Factory and Witkop and Holmes Headquarters, also known as the Weed & Company Building, are two connected historic commercial buildings located in downtown Buffalo, Erie County, New York. The Sibley & Holmwood Candy Factory (149 Swan Street) was built in 1896 and is a five-story, nine-bay-wide brick ...
A New York judge clarified his ruling after appearing to strike down all cannabis ... Mid stage marijuana plants at the Cleveland School of Cannabis Monday, March 11, 2024. ... 2024. The company ...
Website. cannabis.ny.gov. The Office of Cannabis Management is a New York state government agency established upon passage of the Marijuana Regulation and Taxation Act (MRTA) to implement a regulatory framework for medical and adult-use cannabis in the state of New York, along with hemp regulations as well. It was announced by Governor Andrew ...
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. [1] [2] Tilray also has operations in Canada, Australia, New Zealand, [3] [4] and Latin America, [5] with growing facilities in Germany and Portugal. [6] [7]
An act in relation to constituting chapter 7-A of the consolidated laws, in relation to the creation of a new office of cannabis management, as an independent entity within the division of alcoholic beverage control, providing for the licensure of persons authorized to cultivate, process, distribute and sell cannabis and the use of cannabis by persons aged twenty-one or older;
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.